FindTrial
Sign In

Inhibition of retina angiogenesis by interupting CD73 to modulate adenosine homeostasis

Role of adonesine hemeostasis imbalance in the retina angiogenesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003892
Enrollment
Unknown
Registered
2013-10-21
Start date
2012-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retina angiogenesis desease

Interventions

angiogenesis group:no
non-angiogenesis group:no

Sponsors

Department of Ophthalmology, Daping Hospital, Institute of Field Surgery, The Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patient who need vitrectomy but with Proliferative diabetic retinopathy (the neovessels should be confirmed by FFA examination).

Exclusion criteria

Exclusion criteria: retina non-neovascular disease, such as rhegmatogenous retinal detachment, idio macular hole, etc, but all the patient should exclude diabetes

Design outcomes

Primary

MeasureTime frame
adenosine;CD73 enzym;—

Countries

China

Contacts

Public ContactJian Ye

Department of Ophthalmology, Daping Hospital, Institute of Field Surgery, The Third Military Medical University

yejian1979@126.com+86 023 68757765

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026